Treatment of atherosclerotic renovascular hypertension: Review of observational studies and a meta-analysis of randomized clinical trials

Nephrology Dialysis Transplantation

Volumn 30, Issue 4, 2015, Pages 541-553

  Caielli, Paola ^a   Frigo, Anna Chiara ^a   Pengo, Martino F ^a   Rossitto, Giacomo ^a   Maiolino, Giuseppe ^a   Seccia, Teresa Maria ^a   Calò, Lorenzo A ^a   Miotto, Diego ^a   Rossi, Gian Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

controlled randomized clinical trials; renal artery stenosis; renovascular hypertension; transluminal angioplasty

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ENDOVASCULAR SURGERY; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; META ANALYSIS; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENOVASCULAR HYPERTENSION; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; COMPLICATION; HYPERTENSION, RENOVASCULAR; RENAL ARTERY OBSTRUCTION;

ATHEROSCLEROSIS; HUMANS; HYPERTENSION, RENOVASCULAR; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL ARTERY OBSTRUCTION; RISK FACTORS;

EID: 84926645954     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu072     Document Type: Review

References (45)

1. Krijnen P, van Jaarsveld BC, Steyerberg EW et al. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998; 129: 705-711
2. Montecucco F, Pende A, Mach F. The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. Mediat Inflamm 2009; 2009: 752406
3. Olin JW. Role of duplex ultrasonography in screening for significant renal artery disease. Urol Clin North Am 1994; 21: 215-226
4. Paul JF, Cherrak I, Jaulent MC et al. Interobserver variability in the interpretation of renal digital subtraction angiography. AJR Am J Roentgenol 1999; 173: 1285-1288
5. Grüntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978; 1: 263
6. Cognet F, Garcier JM, Dranssart M et al. Percutaneous transluminal renal angioplasty in atheroma with renal failure: long-term outcomes in 99 patients. Eur Radiol 2001; 11: 2524-2530
7. Alhadad A, Mattiasson I, Ivancev K et al. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis. Int Angiol 2009; 28: 106-112
8. Dichtel LE, Gurevich D, Rifkin B et al. Renal artery revascularization in patients with atherosclerotic renal artery stenosis and impaired renal function: conservative management versus renal artery stenting. Clin Nephrol 2010; 74: 113-122
9. Harden PN, MacLeod MJ, Rodger RS et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-1136
10. Watson PS, Hadjipetrou P, Cox SV et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-1677
11. Muray S, Martín M, Amoedo ML et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 2002; 39: 60-66
12. Leertouwer TC, Derkx FH, Pattynama PM et al. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int 2002; 62: 574-579
13. Coen G, Moscaritolo E, Catalano C et al. Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stenting. BMC Nephrol 2004; 5: 15
14. Zeller T, Frank U, Müller C et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003; 108: 2244-2249
15. Zeller T, Frank U, Müller C et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004; 11: 95-106
16. Rivolta R, Bazzi C, Stradiotti P et al. Stenting of renal artery stenosis: is it beneficial in chronic renal failure? J Nephrol 2005; 18: 749-754
17. Kalra PA, Chrysochou C, Green D et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv 2010; 75: 1-10
18. Plouin PF, Chatellier G, Darne B et al. BP outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-829
19. Zeller T, Müller C, Frank U et al. Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv 2003; 60: 1-6
20. Webster J, Marshall F, Abdalla M et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12: 329-335
21. Van Jaarsveld BC, Krijnen P, Pieterman H et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342: 1007-1014
22. Katzen BT, Chang J, Lukowsky GH et al. Percutaneous transluminal angioplasty for treatment of renovascular hypertension. Radiology 1979; 131: 53-58
23. Bax L, Woittiez AJ, Kouwenberg HJ et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009; 150: 840-848
24. Wheatley K, Ives N, Gray R et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009; 361: 1953-1962
25. Cooper CJ, Murphy TP, Cutlip DE et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014; 370: 13-22
26. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-752654
27. Scarpioni R, Michieletti E, Cristinelli L et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). J Nephrol 2005; 18: 423-428
28. da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem 2007; 15: 508-511
29. Rossi GP, Seccia TM, Miotto D et al. The medical and endovascular treatment of atherosclerotic renal artery stenosis (METRAS) study: rationale and study design. J Hum Hypertens 2012; 26: 507-516
30. Ives NJ, Wheatley K, Stowe RL et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transpl 2003; 18: 298-304
31. Nordmann AJ, Woo K, Parkes R et al. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003; 114: 44-50
32. Kumbhani DJ, Bavry AA, Harvey JE et al. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis; a meta-analysis of randomized controlled trials. Am Heart J 2011; 161: 622-630
33. Shetty R, Biondi-Zoccai GG, Abbate A et al. Percutaneous renal artery intervention versus medical therapy in patients with renal artery stenosis: a meta-analysis. EuroIntervention 2011; 7: 844-851
34. White CJ. Kiss my Astral: one seriously flawed study of renal stenting after another. Catheter Cardiovasc Interv 2010; 75: 305-307
35. Henry M, Benjelloun A, Henry I et al. Renal angioplasty and stenting: is it still indicated after ASTRAL and STAR studies? J Cardiovasc Surg 2010; 51: 701-720
36. Sarac TP. Influence and critique of the ASTRAL and CORAL Trials. Semin Vasc Surg 2011; 24: 162-166
37. Giannattasio C, Failla M, Hennig M et al. Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2005; 23: 557-562
38. Safian RD, Madder RD. Refining the approach to renale artery revascularization. J Am Coll Cardiol Cardiovasc Interv 2009; 2: 161-174
39. Hansen KJ, Lundberg AH, Benjamin ME et al. Is renal revascularization in diabetic patients worthwhile? J Vasc Surg 1996; 24: 383-393
40. Burnier M, Brown RE, Ong SH et al. Issues in blood pressure control and the potential role of single-pill combination therapies. Int J Clin Pract 2009; 63: 790-798
41. Khosla S, White CJ, Collins TJ et al. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol 1997; 80: 363-366
42. Vis MM, Sjauw KD, van der Schaaf RJ et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J 2007; 154: 1184-1190
43. Ergelen M, Uyarel H, Cicek G et al. Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both? Acta Cardiol 2010; 65: 415-423
44. Cicek G, Uyarel H, Ergelen M et al. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011; 22: 131-137
45. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005; 112: 1362-1374